Prostate cancer (PCa) is associated with high incidence rates in developed countries and increasing rates in developing areas, especially in those in which prostate-specific antigen (PSA) testing is available for asymptomatic men [1]. This evidence concerns the gene KLK3 and prostate carcinoma.